RajkotUpdates.News: Zydus Needle-Free Corona Vaccine Zycov-D
The COVID-19 pandemic has affected millions of people worldwide & has led to the development of vaccines to combat the virus. In India, Zydus Cadila has developed a needle-free COVID-19 vaccine called Zycov-D, which has recently received approval for emergency use from the Drug Controller General of India. This article will discuss the details of the Zycov-D vaccine & its potential impact on the fight against the pandemic.
What is the Zycov-D vaccine?
The Zycov-D vaccine is a DNA-based vaccine developed by Zydus Cadila. Unlike traditional vaccines, which are administered through needles, this vaccine is delivered using a needle-free applicator. The vaccine uses a plasmid DNA platform, which allows it to generate an immune response against the virus!
How does the vaccine work?
The Zycov-D vaccine works by delivering a small piece of the virus’s DNA into the body. This piece of DNA is known as a plasmid, & it contains the genetic code for the spike protein found on the surface of the coronavirus. Once the plasmid is inside the body, it instructs cells to produce the spike protein. The immune system recognizes the spike protein as foreign & produces antibodies to fight it!
What are the advantages of the Zycov-D vaccine?
One of the primary advantages of the Zycov-D vaccine is that it does not require needles for administration. This makes the vaccine much easier to distribute & can help increase vaccination rates. Additionally, the vaccine does not need to be stored at extremely cold temperatures, which can simplify the logistics of vaccine distribution!
What are the potential side effects of the vaccine?
Like all vaccines, the Zycov-D vaccine can cause side effects. The most common side effects include pain or swelling at the injection site, headache, fatigue, & fever. However, these side effects are generally mild & go away on their own within a few days!
How effective is the vaccine?
Clinical trials have shown that the Zycov-D vaccine is safe & effective. In phase 3 trials, the vaccine was found to be 66.6% effective at preventing symptomatic COVID-19. Additionally, the vaccine was found to be 100% effective at preventing moderate to severe COVID-19.
You can read this similar topics article:
Who is eligible to receive the vaccine?
The Zycov-D vaccine is currently approved for use in individuals 12 years of age and older. The vaccine is administered in two doses, with the second dose given 28 days after the first dose.
The Zycov-D vaccine represents an important step forward in the fight against the COVID-19 pandemic. Its needle-free delivery system & ease of distribution make it a promising option for increasing vaccination rates. Additionally, its effectiveness in preventing moderate to severe COVID-19 is encouraging. As more people become vaccinated, we can hopefully bring an end to the pandemic & return to normalcy!